Frequency and risk factors of spontaneous hemorrhagic transformation following ischemic stroke on the initial brain CT or MRI: data from the China National Stroke Registry (CNSR)

References

• Hart RG, Easton JD. Hemorrhagic infarcts. Stroke. 1986;17:586–9.10.1161/01.STR.17.4.586
   PubMed Web of Science ®Google Scholar
• Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, et al. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the stroke-acute ischemic NXY treatment (SAINT) I and SAINT II trials. Stroke. 2009;40:3067–72.10.1161/STROKEAHA.109.554386
   PubMed Web of Science ®Google Scholar
• Molina CA, Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001;32:1079–84.10.1161/01.STR.32.5.1079
   PubMed Web of Science ®Google Scholar
• D’Amelio M, Terruso V, Famoso G, et al. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:649–54.10.1016/j.jstrokecerebrovasdis.2013.06.005
   PubMed Web of Science ®Google Scholar
• Alexandrov AV, Black SE, Ehrlich LE, Caldwell CB, Norris JW. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke. Stroke. 1997;28:1198–202.10.1161/01.STR.28.6.1198
   PubMed Web of Science ®Google Scholar
• Lindley RI, Wardlaw JM, Sandercock PA, et al. Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction. J Stroke Cerebrovasc Dis. 2004;13:235–46.10.1016/j.jstrokecerebrovasdis.2004.03.003
   PubMedGoogle Scholar
• Wang Z, Xu C, Wang P, Wang Y, Xin H. Combined clopidogrel-aspirin treatment for high risk TIA or minor stroke does not increase cerebral microbleeds. Neurol Res. 2015;37:993–7.10.1179/1743132815Y.0000000087
   PubMed Web of Science ®Google Scholar
• Wang Y, Cui L, Ji X, et al. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke. 2011;6:355–61.10.1111/ijs.2011.6.issue-4
   PubMed Web of Science ®Google Scholar
• Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521–6.10.1016/0140-6736(91)93206-O
   PubMed Web of Science ®Google Scholar
• Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Wang PL, Zhao XQ, Du WL, et al. In-hospital medical complications associated with patient dependency after acute ischemic stroke: data from the China National Stroke Registry. Chin Med J (Engl). 2013;126:1236–41.
   PubMed Web of Science ®Google Scholar
• Arnould MC, Grandin CB, Peeters A, Cosnard G, Duprez TP. Comparison of CT and three MR sequences for detecting and categorizing early (48 h) hemorrhagic transformation in hyperacute ischemic stroke. AJNR Am J Neuroradiol. 2004;25:939–44.
   PubMed Web of Science ®Google Scholar
• Terruso V, D’Amelio M, Di Benedetto N, et al. Frequency and determinants for hemorrhagic transformation of cerebral infarction. Neuroepidemiology. 2009;33:261–5.10.1159/000229781
   PubMed Web of Science ®Google Scholar
• Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32:438–41.10.1161/01.STR.32.2.438
   PubMed Web of Science ®Google Scholar
• Álvarez-Sabín J, Maisterra O, Santamarina E, Kase CS. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol. 2013;12:689–705.10.1016/S1474-4422(13)70055-3
   PubMed Web of Science ®Google Scholar
• Adams HP Jr. Emergent use of anticoagulation for treatment of patients with ischemic stroke. Stroke. 2002;33:856–61.10.1161/hs0302.104628
   PubMed Web of Science ®Google Scholar
• Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–7.10.1016/S0140-6736(04)16721-4
   PubMed Web of Science ®Google Scholar
• Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction–a prospective study. Stroke. 1986;17:179–85.10.1161/01.STR.17.2.179
   PubMed Web of Science ®Google Scholar
• Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;79:S52–7.10.1212/WNL.0b013e3182697e70
   PubMed Web of Science ®Google Scholar
• Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012;43:2904–9.10.1161/STROKEAHA.112.665331
   PubMed Web of Science ®Google Scholar
• Fisher M, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol. 1951;10:92–4.
   PubMed Web of Science ®Google Scholar
• Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the framingham heart study. Stroke. 2009;40:1032–7.10.1161/STROKEAHA.108.542894
   PubMed Web of Science ®Google Scholar
• Eriksson M, Glader EL, Norrving B, Terent A, Stegmayr B. Sex differences in stroke care and outcome in the Swedish national quality register for stroke care. Stroke. 2009;40:909–14.10.1161/STROKEAHA.108.517581
   PubMed Web of Science ®Google Scholar
• Haorah J, Schall K, Ramirez SH, Persidsky Y. Activation of protein tyrosine kinases and matrix metalloproteinases causes blood-brain barrier injury: Novel mechanism for neurodegeneration associated with alcohol abuse. Glia. 2008;56:78–88.10.1002/(ISSN)1098-1136
   PubMed Web of Science ®Google Scholar
• Zhao DL, Deng G, Xie B, et al. Wall characteristics and mechanisms of ischaemic stroke in patients with atherosclerotic middle cerebral artery stenosis: a high-resolution MRI study. Neurol Res. 2016;1–8.
   PubMed Web of Science ®Google Scholar